-
公开(公告)号:US20230348420A1
公开(公告)日:2023-11-02
申请号:US18002291
申请日:2021-06-24
申请人: Novartis AG
发明人: Nicolas AMIOT , Darija DEDIC , Peng FU , Fabrice GALLOU , Xingxian GU , Cornelius HARLACHER , Siqian LIU , Shuping YAO , Jiong YE , Jianguang ZHOU
IPC分类号: C07D401/12 , C07D401/14 , C07D237/08 , C07D231/14
CPC分类号: C07D401/12 , C07D401/14 , C07D237/08 , C07D231/14
摘要: The invention relates to a novel process, novel process step(s) and novel intermediate(s) useful for the preparation of 1,4-disubstituted pyridazine compounds, such as 5-(1H-Pyrazol-4-yl)-2-(6-((2,2,6,6-tetramethylpiperidin-4-yl)oxy)pyridazin-3-yl)phenol.
-
公开(公告)号:US20240360118A1
公开(公告)日:2024-10-31
申请号:US18506164
申请日:2023-11-10
申请人: Novartis AG
发明人: Vincent BORDAS , Jvan BRUN , Andrea DECKER , Markus FUREGATI , Geoffrey GOGNIAT , Wanben GONG , Jacques HAMON , Jürgen Hans-Hermann HINRICHS , Philipp HOLZER , Fatma LIMAM , Henrik MÖBITZ , Sandro NOCITO , Simone PLATTNER , Niko SCHMIEDEBERG , Joseph SCHOEPFER , Jessica SOTO , Ross Sinclair STRANG , Shuping YAO , Huangchao YU , Frédéric ZECRI , Sisi ZHANG
IPC分类号: C07D413/14 , C07D401/14 , C07D405/14
CPC分类号: C07D413/14 , C07D401/14 , C07D405/14 , C07B2200/13
摘要: The present invention provides a compound, or a pharmaceutically acceptable salt thereof, of formula (I):
wherein R1, R2, R3, R4, R5, R26, R27, y, R, M, W, L, V, T, Y, J, K and A are as described herein, therapeutic uses of said compounds, uses of said compounds as research chemicals, a pharmaceutical composition and combinations comprising said compounds, and methods for manufacturing the compounds of the invention.-
公开(公告)号:US20230046859A1
公开(公告)日:2023-02-16
申请号:US17824407
申请日:2022-05-25
申请人: NOVARTIS AG
发明人: Vincent BORDAS , Jvan BRUN , Andrea DECKER , Markus FUREGATI , Geoffrey GOGNIAT , Wanben GONG , Jacques HAMON , Jürgen Hans-Hermann HINRICHS , Philipp HOLZER , Fatma LIMAM , Henrik MÖBITZ , Sandro NOCITO , Simone PLATTNER , Niko SCHMIEDEBERG , Joseph SCHOEPFER , Jessica SOTO , Ross Sinclair STRANG , Shuping YAO , Huangchao YU , Frédéric ZECRI , Sisi ZHANG
IPC分类号: C07D413/14 , C07D401/14 , C07D405/14
摘要: The present invention provides a compound, or a pharmaceutically acceptable salt thereof, of formula (I): wherein R1, R2, R3, R4, R5, R26, R27, y, R, M, W, L, V, T, Y, J, K and A are as described herein, therapeutic uses of said compounds, uses of said compounds as research chemicals, a pharmaceutical composition and combinations comprising said compounds, and methods for manufacturing the compounds of the invention.
-
-